adults are currently taking a GLP-1 medication, translating to tens of millions of people, and use continues to climb
Krogh, his wife Marie a doctor who was living with diabetes, scientist Hans Christian Hagedorn, and pharmacist August Kongsted established Nordisk Insulinboratorium in 1923 and start producing and commercializing insulin in Denmark
GLP-1 treatments produce reliable metabolic benefits, such as reduced body mass index and improved total body glucose levels
See also: Why Peptide Quality Still Matters Even with correct solvent choice, results depend heavily on the quality of the peptide itself
But some doctors warned they were seeing patients with serious, life-threatening complications including seizures, bowel obstruction and inflammation of the pancreas, known as pancreatitis